SCHEMBL5459667

SCHEMBL5459667

Fc1cc(F)c2nc(Nc3ccc(Oc4ccc5c(c4)OCO5)cc3)[nH]c2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 1/20 0.44
MAPK1 P28482 2/20 0.41
ALDH1A1 P00352 1/20 0.41
CHEK2 O96017 1/20 0.39
DYRK1A Q13627 3/20 0.38
DYRK2 Q92630 3/20 0.38
DYRK1B Q9Y463 3/20 0.38
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
USP2 O75604 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
ALOX15 P16050 1/20 0.37
CYP2C19 P33261 1/20 0.37
HSD17B10 Q99714 1/20 0.37
CLK4 Q9HAZ1 1/20 0.37
CSNK1A1 P48729 1/20 0.37
CSNK1D P48730 1/20 0.37
NOS2 P35228 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5447112 0.85 PDE10A (0.49) SYKMAPK1ALDH1A1CHEK2DYRK1A
SCHEMBL5444062 0.82 SYK (0.45) SYKMAPK1ALDH1A1CHEK2DYRK1A
SCHEMBL5449703 0.80 RIPK1 (0.42) SYKMAPK1ALDH1A1CHEK2DYRK1A
SCHEMBL5450105 0.80 KDR (0.44) SYKMAPK1ALDH1A1CHEK2DYRK1A
SCHEMBL5447392 0.78 CSNK1A1 (0.42) ALDH1A1MEN1KMT2ACSNK1A1CSNK1D
SCHEMBL5451994 0.74 RIPK1 (0.42) SYKKMT2ACSNK1A1CSNK1DPDE10A
SCHEMBL2489990 0.70 PDE10A (0.61) PDE10A
SCHEMBL4161466 0.70 KDR (0.53) DYRK1ADYRK1BCSNK1A1CSNK1DPDE10A
SCHEMBL5456254 0.69 RAF1 (0.44) DYRK1ADYRK1BCSNK1A1CSNK1DPDE10A
SCHEMBL5459673 0.69 CYP1A2 (0.36) CYP1A2CYP3A4CYP2D6CYP2C19CSNK1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070021456-A1 Aminobenzimidazole derivatives MERCK PATENT GMBH (DE) 2007-01-25 US claimed
US-20070021456-A1 Aminobenzimidazole derivatives MERCK PATENT GMBH (DE) 2007-01-25 US disclosed
US-20070021456-A1 Aminobenzimidazole derivatives MERCK PATENT GMBH (DE) 2007-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070021456-A1 Aminobenzimidazole derivatives TIE1, KDR, FLT1 SYK 189/4885MAPK1 506/4885ALDH1A1 1159/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.